HeartCore Psykoterapi ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 17.6% 13.7% 15.8% 16.4%  
Credit score (0-100)  0 9 15 11 10  
Credit rating  N/A B BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 211 456 234 624  
EBITDA  0.0 96.9 -94.0 -6.5 202  
EBIT  0.0 96.9 -94.0 -6.5 202  
Pre-tax profit (PTP)  0.0 95.2 -95.5 -7.0 201.6  
Net earnings  0.0 73.9 -74.5 -5.5 157.2  
Pre-tax profit without non-rec. items  0.0 95.2 -95.5 -7.0 202  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 114 39.4 33.9 191  
Interest-bearing liabilities  0.0 1.0 36.8 15.5 12.1  
Balance sheet total (assets)  0.0 183 120 87.1 263  

Net Debt  0.0 -182 -62.1 -49.0 -251  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 211 456 234 624  
Gross profit growth  0.0% 0.0% 116.1% -48.7% 167.1%  
Employees  0 1 0 0 0  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 183 120 87 263  
Balance sheet change%  0.0% 0.0% -34.7% -27.3% 201.8%  
Added value  0.0 96.9 -94.0 -6.5 201.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 -1.0 -2.0 1.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 46.0% -20.6% -2.8% 32.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 52.8% -62.0% -6.3% 115.2%  
ROI %  0.0% 84.4% -98.4% -10.3% 159.6%  
ROE %  0.0% 64.9% -97.3% -14.9% 139.8%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 62.1% 32.8% 38.9% 72.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -188.3% 66.0% 755.6% -124.4%  
Gearing %  0.0% 0.8% 93.5% 45.8% 6.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 362.6% 8.1% 2.0% 0.0%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 2.6 1.5 1.6 3.7  
Current Ratio  0.0 2.6 1.5 1.6 3.7  
Cash and cash equivalent  0.0 183.4 98.9 64.5 262.9  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 113.9 39.4 33.9 191.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 97 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 97 0 0 0  
EBIT / employee  0 97 0 0 0  
Net earnings / employee  0 74 0 0 0